Zobrazeno 1 - 10
of 13
pro vyhledávání: '"T. S. Teptsova"'
Autor:
V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva
Publikováno v:
Фармакоэкономика, Vol 16, Iss 2, Pp 283-290 (2023)
The use of real-world data (RWD) and real-world evidence (RWE) in process of improving public health, their assessment, and use in decision making is a promising area. Discussions are actively underway about the possibility of using RWD and RWE in ro
Externí odkaz:
https://doaj.org/article/22c4e3a2073042ada0fe2ad109974e62
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 28-35 (2021)
The study aims to estimate the MitraClip system’s cost-effectiveness compared with optimal medical therapy in adult patients with inoperable mitral regurgitation and assess its impact on the budget of the Russian Federation health system.Materials
Externí odkaz:
https://doaj.org/article/bb31ea8b95f943b58cf993bc8cb64ff2
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 367-376 (2021)
Introduction. Presently, the willingness-to-pay threshold (cost-effectiveness threshold, incremental cost-effectiveness ratio) is used as one of the decision-making criteria for reimbursement in some foreign countries with a developed system of healt
Externí odkaz:
https://doaj.org/article/5134d26ead4649258bfe6bbe8ba84fe1
Publikováno v:
Фармакоэкономика, Vol 11, Iss 4, Pp 3-15 (2019)
The aim is to analyze the medical records of patients with malignant lymphoproliferative diseases (LPD) in the Russian Federation in 2016- 2017. Materials and methods. Treating physicians in 75 regions of the Russian Federation were asked to fill the
Externí odkaz:
https://doaj.org/article/336ce1b6b94c47e1a7393ec0c41f1a42
Autor:
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov
Publikováno v:
Фармакоэкономика, Vol 11, Iss 3, Pp 13-22 (2018)
The aim was to develop a methodology for determining the willingness to pay threshold (WTPT) and its upper limit value within the Russian health care system.Materials and methods. WTPT was calculated based on the shadow budget price (i. e. determinin
Externí odkaz:
https://doaj.org/article/328fb7373f08455ea7b23e2dcf1ba3c1
Publikováno v:
Eurasian heart journal. :28-35
The study aims to estimate the MitraClip system’s cost-effectiveness compared with optimal medical therapy in adult patients with inoperable mitral regurgitation and assess its impact on the budget of the Russian Federation health system.Materials
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 367-376 (2021)
Introduction. Presently, the willingness-to-pay threshold (cost-effectiveness threshold, incremental cost-effectiveness ratio) is used as one of the decision-making criteria for reimbursement in some foreign countries with a developed system of healt
Publikováno v:
Russian Journal of Genetics. 56:1391-1405
Genetic predisposition is one of the main risk factors for developing breast cancer (BC) and ovarian cancer (OC). We conducted an analysis of the epidemiology of BRCA1 and BRCA2 gene mutations in the Russian population and analyzed domestic and inter
Publikováno v:
Фармакоэкономика, Vol 11, Iss 4, Pp 3-15 (2019)
The aimis to analyze the medical records of patients with malignant lymphoproliferative diseases (LPD) in the Russian Federation in 2016- 2017.Materials and methods. Treating physicians in 75 regions of the Russian Federation were asked to fill the s
Autor:
G. R. Hachatryan, V. K. Fedyaeva, N. Z. Musina, T. S. Teptsova, V. V. Tarasov, T. P. Bezdenezhnyh
Publikováno v:
Фармакоэкономика, Vol 11, Iss 3, Pp 13-22 (2018)
The aim was to develop a methodology for determining the willingness to pay threshold (WTPT) and its upper limit value within the Russian health care system.Materials and methods. WTPT was calculated based on the shadow budget price (i. e. determinin